Age-related macular degeneration

Age-related macular degeneration (AMD) is a leading cause of vision loss in people over 50. AMD affects the macula, the central part of the retina responsible for sharp, central vision. Our treatment options for AMD include:

Dry AMD treatment

Wet AMD treatment

AMD treatment aims to slow the progression of the disease and preserve vision. Early diagnosis and intervention are critical for maintaining visual function and quality of life.

Dry AMD is characterised by the presence of drusen, and small yellow deposits under the retina. Treatment for dry AMD includes photobiomodulation therapy with the Valeda Light Delivery System (LDS), which uses light to stimulate cellular function and reduce drusen. Additionally, anti-VEGF injections of Syfovre (Pegcetacoplan) are being introduced to treat geographic atrophy, a severe form of dry AMD.

Wet AMD occurs when abnormal blood vessels grow under the retina and leak fluid or blood, causing rapid vision loss. Treatment for wet AMD focuses on anti-VEGF (vascular endothelial growth factor) therapy, which helps reduce the growth of these abnormal blood vessels. Our treatment options include intravitreal injections of Vabysmo, Eylea, Lucentis, and Avastin. These injections help to stabilise vision and, in some cases, improve it by reducing fluid leakage and preventing further damage.

What our patients say

Book an appointment

Booking an appointment with Ms Ranjit Sandhu is the first step towards managing AMD and protecting your vision. We offer convenient and flexible appointment scheduling to accommodate your needs.

FAQs on AMD Treatment

AMD is a degenerative eye disease that affects the macula, leading to central vision loss. It is most common in older adults and can severely impact daily activities such as reading, driving, and recognising faces.
Symptoms of AMD include blurred or distorted central vision, difficulty seeing in low light, and the appearance of dark or empty areas in the centre of your vision. An eye examination by an Ophthalmologist can diagnose AMD and determine the appropriate treatment.
Anti-VEGF injections reduce the growth of abnormal blood vessels and fluid leakage in the retina, helping to stabilise or improve vision. These treatments can slow the progression of wet AMD and, in some cases, restore some lost vision.
Certain vitamins, as specifically used in Age-Related Eye Disease Studies (AREDS/AREDS2), such as the antioxidant plant pigments Lutein and Zeaxanthin, vitamins C and E, and the minerals zinc and copper, showed that the risk of developing wet age-related macular degeneration in high-risk dry age-related macular degeneration was reduced by 25%.
Recovery time varies depending on the type and severity of AMD and the treatment used. Anti-VEGF injections typically require ongoing treatments, often monthly or bimonthly, to maintain their effectiveness. Your ophthalmologist will provide detailed care instructions and schedule follow-up appointments to monitor your progress.

Our Price List

Standard cataract surgeryEnhanced cataract surgery
New consultation £320
Follow up £280
– Monofocal lens £2450
– Monofocal toric lens £2750
– Extended depth of focus (EDoF) £2950
– Extended depth of focus (EDoF) toric £3250
Advanced cataract surgery (spectacle independence)
– Multifocal lens £3250
– Multifocal toric lens £3525
The PBM treatment cycle consists of nine sessions over three weeks on non-consecutive days, such as Monday, Wednesday, and Friday. Two to three treatment cycles per year are required to maintain benefits.

Further information can be found from:

Macular Society:
help@macularsociety.org

Royal National Institute for the Blind:
helpline@rnib.org.uk